
What is M.A.S.C.O.T?
A unique collaboration of blood and liver doctors, working with patients to improve their quality of life and treatment options.
It will aim to gather much-needed data to help understand, manage and treat the MPN-SVT condition (What is MPN-SVT?)
The registry will enable:
- A significant opportunity for doctors to improve patient outcomes
- Better fact-based decision making by doctors and patients
- Inform and share best practice
- Development and advancement of treatment.
‘(Of MPN-SVT) we know very little of treatment patterns and outcomes in UK and there are no clinical trials for new treatments on offer for this complex condition. Our aim with the MASCOT Registry is to capture UK data on clinical outcomes and treatment decisions. The registry data will be available to clinicians and scientists to improve services and develop further research questions’
Dr Mallika Sekhar MBBS, MD, FRCP, FRCPath Consultant Haematologist Royal Free London NHS Trust, University College London Hospitals NHS Trust and Honorary Associate Professor, UCL School of Medicine.


